Contineum Therapeutics, Inc. Class A Common Stock (NASDAQ: CTNM) last traded at $8.32, down 2.86% on the session. The quote above updates while this page is open; the figures below are drawn from Contineum Therapeutics, Inc. Class A Common Stock’s own filings and are restated only when a new one is published.
Contineum Therapeutics, Inc. Class A Common Stock trades on NASDAQ under the ticker CTNM. Its market capitalisation is $192.19 million.
Valuation measures for Contineum Therapeutics, Inc. Class A Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $192.19M |
|---|---|
| Enterprise value | $188.18M |
| Price / book | 0.80 |
| Beta | 1.28 |
Trailing-twelve-month figures tagged in Contineum Therapeutics, Inc. Class A Common Stock's XBRL filings with the SEC.
| Net income (TTM) | -$57.56M |
|---|---|
| Return on equity | -24.02% |
| Cash | $14.71M |
Range and volume for CTNM over the past 52 weeks.
| 52-week high | $17.79 |
|---|---|
| 52-week low | $8.10 |
| Volume | 1.09M |
| Average volume | 655.1K |
| Previous close | $8.57 |
Invest a chosen dollar amount in Contineum Therapeutics, Inc. Class A Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell CTNM.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.